RNA-editing oligonucleotides and uses thereof
US12031131B2 · kind B2 · utility
0Cited by
9References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 3, 2023 |
| Grant date | Jul 9, 2024 |
| Priority date | — |
| Expiry date | May 3, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/351
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure features useful compositions and methods to treat disorders for which deamination of an adenosine in an mRNA produces a therapeutic result.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.